Violacein enhances the cytotoxic effect of commonly used chemotherapeutics on rhabdomyosarcoma cells
Аутори
Milošević, EmilijaJasnić, Jovana
Stanisavljević, Nemanja
Cenni, Vittoria
Bavelloni, Alberto
Kojić, Snežana
Остала ауторства
Čavić, MilenaКонференцијски прилог (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
Investigati on of natural compounds showing specific toxicity to tumor cells aims to improve the efficacy
of available therapies. Our previous research demonstrated the cytotoxic acti vity of the bacterial pigment violacein
against rhabdomyosarcoma (RMS) cell lines. RMS is the most common soft tissue malignancy in children. In this
study, we evaluated the cytotoxicity of violacein on RMS cells in combinati on with conventi onal chemotherapeutics
doxorubicin, irinotecan, and vinflunine.
Кључне речи:
antineoplastic agents / cytotoxicity / doxorubicin / rhabdomyosarcoma / violaceinИзвор:
6th Congress of the Serbian Association for Cancer Research (SDIR), 2023, 1, 94-94Издавач:
- Belgrade : Serbian Association on for Cancer Research
Колекције
Институција/група
Institut za molekularnu genetiku i genetičko inženjerstvoTY - CONF AU - Milošević, Emilija AU - Jasnić, Jovana AU - Stanisavljević, Nemanja AU - Cenni, Vittoria AU - Bavelloni, Alberto AU - Kojić, Snežana PY - 2023 UR - https://imagine.imgge.bg.ac.rs/handle/123456789/2101 AB - Investigati on of natural compounds showing specific toxicity to tumor cells aims to improve the efficacy of available therapies. Our previous research demonstrated the cytotoxic acti vity of the bacterial pigment violacein against rhabdomyosarcoma (RMS) cell lines. RMS is the most common soft tissue malignancy in children. In this study, we evaluated the cytotoxicity of violacein on RMS cells in combinati on with conventi onal chemotherapeutics doxorubicin, irinotecan, and vinflunine. PB - Belgrade : Serbian Association on for Cancer Research C3 - 6th Congress of the Serbian Association for Cancer Research (SDIR) T1 - Violacein enhances the cytotoxic effect of commonly used chemotherapeutics on rhabdomyosarcoma cells EP - 94 IS - 1 SP - 94 UR - https://hdl.handle.net/21.15107/rcub_imagine_2101 ER -
@conference{ author = "Milošević, Emilija and Jasnić, Jovana and Stanisavljević, Nemanja and Cenni, Vittoria and Bavelloni, Alberto and Kojić, Snežana", year = "2023", abstract = "Investigati on of natural compounds showing specific toxicity to tumor cells aims to improve the efficacy of available therapies. Our previous research demonstrated the cytotoxic acti vity of the bacterial pigment violacein against rhabdomyosarcoma (RMS) cell lines. RMS is the most common soft tissue malignancy in children. In this study, we evaluated the cytotoxicity of violacein on RMS cells in combinati on with conventi onal chemotherapeutics doxorubicin, irinotecan, and vinflunine.", publisher = "Belgrade : Serbian Association on for Cancer Research", journal = "6th Congress of the Serbian Association for Cancer Research (SDIR)", title = "Violacein enhances the cytotoxic effect of commonly used chemotherapeutics on rhabdomyosarcoma cells", pages = "94-94", number = "1", url = "https://hdl.handle.net/21.15107/rcub_imagine_2101" }
Milošević, E., Jasnić, J., Stanisavljević, N., Cenni, V., Bavelloni, A.,& Kojić, S.. (2023). Violacein enhances the cytotoxic effect of commonly used chemotherapeutics on rhabdomyosarcoma cells. in 6th Congress of the Serbian Association for Cancer Research (SDIR) Belgrade : Serbian Association on for Cancer Research.(1), 94-94. https://hdl.handle.net/21.15107/rcub_imagine_2101
Milošević E, Jasnić J, Stanisavljević N, Cenni V, Bavelloni A, Kojić S. Violacein enhances the cytotoxic effect of commonly used chemotherapeutics on rhabdomyosarcoma cells. in 6th Congress of the Serbian Association for Cancer Research (SDIR). 2023;(1):94-94. https://hdl.handle.net/21.15107/rcub_imagine_2101 .
Milošević, Emilija, Jasnić, Jovana, Stanisavljević, Nemanja, Cenni, Vittoria, Bavelloni, Alberto, Kojić, Snežana, "Violacein enhances the cytotoxic effect of commonly used chemotherapeutics on rhabdomyosarcoma cells" in 6th Congress of the Serbian Association for Cancer Research (SDIR), no. 1 (2023):94-94, https://hdl.handle.net/21.15107/rcub_imagine_2101 .